This post was originally published on this site
Revenue rose 5.1% to $10.10 billion in the third quarter ended Feb. 29, while analysts had expected $9.80 billion, according to Refinitiv IBES data.
Net income fell to $847 million, or 53 cents per share, from $1.10 billion, or 68 cents per share, a year earlier, due to the hit to its Greater China business from the health crisis.
